The ZyprexaKills wiki has issued a call for editorial submissions:

http://zyprexa.pbwiki.com/Editorials
 
We are requesting submissions for editorials and op-eds about this issue 
(500-750 words, maximum). Please send all submissions to zyprexa-discuss at 
acm.jhu.edu, or create a new page in this wiki, and link to it from this one. 
Ideas for possible op-ed topics include: 

   The importance of the "prior restraint" doctrine in the First Amendment
   The effects of omniscient surveillance on whistleblowing 
   The growing threat of soft censorship, and the incongruity between outrage 
at overt oppressive censorship and the complacency for the form it takes in a 
modern liberal democracy.
   The relationship between anonymity and freedom of speech
   Critiques of the psychiatric medical model of mental illness
   A call for pharmaceutical companies to pledge the equivalent of the 
Hippocratic oath, so they are answerable to something other than the bottom 
line.
   Advocating for a pro-choice position towards psychopharmaceuticals, not the 
paternalistic, Big Daddy Pharma (and Mama Lilly) knows best
   The dangers of sales people hawking dangerous, psychiatric medication to 
general internists, even if its on-label
   The slippery slope of zyprexa prescriptions and usage
   The rationale behind FDA regulations and reviews of pharmaceutical marketing 
strategies.
   The dangers of off-label marketing of drugs
   Corporate responsibility and culpable negligence
   The abuse of Medicare by predatory pricing practices
This story is about to get really big, and we have a rare opportunity to 
present these issues to a very wide audience. Many people on this list may have 
existing material that they may wish to re-purpose for this occasion. 

Please circulate this message widely.

Thanks,
- Fletch Lives

 
---------------------------------
It's here! Your new message!
Get new email alerts with the free Yahoo! Toolbar.
_______________________________________________
Zyprexa-discuss mailing list
Zyprexa-discuss@acm.jhu.edu
http://lists.acm.jhu.edu/mailman/listinfo/zyprexa-discuss

Reply via email to